Titanium Dioxide —
The Food Additive the EU Banned
That the UK Still Permits

In January 2022, the European Food Safety Authority concluded that titanium dioxide — the white pigment added to hundreds of foods to make them appear brighter, whiter, and more visually appealing — could no longer be considered safe as a food additive. The evidence that triggered this conclusion was primarily concerned with genotoxicity: the possibility that titanium dioxide nanoparticles, once absorbed from the gut, could cause DNA damage. The EU banned it from food entirely in August 2022.

The UK Food Standards Agency reviewed substantially the same body of evidence and reached the opposite conclusion. E171 remains a permitted food additive in the UK. The FSA's position is that the evidence for harm at realistic dietary exposure levels is not sufficiently robust to justify prohibition. It continues to monitor the situation.

This regulatory divergence is not a Brexit footnote. It is a case study in how the same scientific evidence can generate completely different regulatory outcomes depending on which agency applies which standard of proof — and who bears the cost of being wrong.

E171 — the white that makes
everything look cleaner than it is.

Titanium dioxide is a naturally occurring mineral, mined primarily in Australia, South Africa, and Canada. In its food-grade form it is processed into an extremely fine white powder — so fine that a significant proportion of the particles fall into the nanoparticle range, meaning they are smaller than 100 nanometres in at least one dimension. It has no flavour, no nutritional value, and no functional role beyond appearance. It makes white foods whiter, frostings more opaque, sauces more uniform in colour, and confectionery more visually consistent.

It is currently present in an extensive range of UK food products:

The cumulative exposure picture is one that most people — including most regulatory assessments — do not fully account for. A person consuming white-coated medications, titanium dioxide-containing supplements, toothpaste (some of which is inevitably swallowed), chewing gum, and white confectionery on the same day is receiving E171 from multiple sources simultaneously. Individual product assessments do not capture this cumulative load.

What the evidence actually shows —
and why the EU and UK reached different conclusions.

Titanium dioxide has been used in food since the 1960s. Its safety was assessed under a framework that predates modern nanoparticle science — the original assessments did not distinguish between bulk titanium dioxide and the nanoparticle fraction, which behaves differently in biological systems. The gut mucosa is permeable to nanoparticles in ways it is not permeable to larger particles of the same compound. This is not a fringe concern — it is established nanoparticle biology, and it changes the risk calculation significantly.

The gut lining evidence

Multiple studies — including those conducted in Caco-2 cell models (the gold standard in vitro model for gut epithelial function) and in animal models — have found that titanium dioxide nanoparticle exposure disrupts gut epithelial barrier integrity, alters tight junction protein expression, and promotes intestinal inflammation. The effect on tight junctions is particularly relevant in the context of intestinal permeability (leaky gut) and the inflammatory cascade described in the depression post — the same gut barrier disruption that allows LPS into the bloodstream, triggering the systemic inflammation that reaches the brain.

A 2019 study in the journal Scientific Reports found that chronic exposure to food-grade titanium dioxide in mice altered gut microbiome composition and increased inflammatory markers in colon tissue. A 2021 French study conducted as part of the EFSA assessment found that titanium dioxide nanoparticles induced oxidative stress, impaired mitochondrial function, and disrupted intestinal barrier function in human intestinal cell lines at concentrations considered relevant to dietary exposure.

The genotoxicity concern

The most significant finding driving the EU ban was evidence of genotoxicity — the potential for titanium dioxide nanoparticles to cause DNA damage. EFSA's 2021 opinion concluded that uncertainty about genotoxic potential could not be resolved by the available evidence, and that a No Observed Adverse Effect Level (NOAEL) could not be established. When a safety agency cannot establish a NOAEL — the dose below which no harm is observed — it cannot define a safe exposure level. That is the scientific basis for the EU prohibition.

The UK FSA's position differs not on the underlying science but on the standard of proof required for regulatory action. The FSA concluded that the genotoxicity evidence was not conclusive at realistic dietary exposure levels — meaning the evidence of harm was not strong enough to justify prohibition under the UK's current regulatory framework. It did not conclude that titanium dioxide was safe. It concluded that the evidence was insufficient to ban it.

Why nanoparticles are not
just smaller versions of the same thing.

The particle size distinction is not technical pedantry. It is the central biological issue. At the nanoscale — particles below 100nm — compounds exhibit physical and chemical properties that bulk forms of the same substance do not have. Surface area increases dramatically relative to volume, creating greater reactivity. Particles can cross biological barriers that bulk forms cannot penetrate. The blood-brain barrier, the gut epithelium, and the placenta are all barriers that nanoparticles navigate differently from their larger counterparts.

Titanium dioxide in its food-grade form contains a variable proportion of nanoparticles — estimates range from 17% to over 40% of particles by number falling in the nanoparticle size range, depending on the manufacturing process and product application. The regulatory safety assessment for E171 was conducted on the bulk compound. The nanoparticle fraction was not separately assessed in the original approvals and has only recently been characterised with sufficient precision to enter the risk assessment framework.

This is a recurring pattern in food additive regulation: compounds are approved based on safety data generated under the science available at the time of approval, and as analytical capability improves and new mechanisms are identified, the safety case becomes more complex. The question is not whether titanium dioxide was approved in bad faith in the 1960s — it was not. The question is whether the regulatory response to new mechanistic evidence is proportionate to the potential harm and consistent with the precautionary principle.

Who has the highest exposure —
and who should be most cautious.

Exposure is not uniform across the population. Several groups have disproportionately high titanium dioxide exposure based on dietary patterns and medication use:

Children

The foods with the highest E171 concentrations — white confectionery, chewing gum, sugar-coated sweets, cake decorations — are disproportionately consumed by children. Children also have higher surface area to body weight ratios, meaning equivalent per-kilogram exposure represents a greater systemic load. The gut epithelium of young children is also more permeable than in adults — precisely the characteristic that makes nanoparticle absorption more likely. A child consuming white-coated sweets, chewing gum, and vitamin tablets with titanium dioxide coatings on the same day receives a cumulative exposure that has not been separately assessed or regulated.

People with existing gut inflammation

Gut barrier function is the primary protective mechanism against titanium dioxide nanoparticle absorption. People with pre-existing intestinal permeability — from dysbiosis, inflammatory bowel conditions, food sensitivity, coeliac disease, or chronic stress — have a compromised first line of defence. The same gut lining impairment that allows LPS into the bloodstream allows nanoparticles to cross more readily. Compounds that further disrupt tight junction integrity in an already compromised gut are a compounding concern rather than an independent one.

People on multiple medications

The titanium dioxide exposure from medication coatings is not trivial and is not captured in food exposure assessments. A person taking three or four tablets daily — thyroid medication, an antidepressant, a blood pressure medication, a vitamin D supplement — may be consuming E171 in significant quantities from this route alone. Unlike food, medication coatings are not subject to the same labelling considerations for additives, and patients are not typically informed that their tablets contain a compound the EU has banned from food.

The pattern this series
keeps returning to.

The titanium dioxide situation has a different character from folic acid fortification or Bovaer in dairy. There is no public health rationale for E171. It exists in food entirely for aesthetic purposes — to make products look whiter and more visually appealing. There is no nutritional benefit, no preservation function, no safety function. It is a cosmetic additive that makes profit for the manufacturers of processed food products by making them appear more desirable.

The EU concluded that this additive cannot be demonstrated safe and banned it. The UK concluded that the evidence of harm is not conclusive enough to remove it. The consumer has no mechanism to identify which products contain it without reading every label. There is no warning. There is no opt-out. And unlike the folic acid fortification case — where at least the stated rationale is a genuine public health goal — there is no public health case to make for keeping E171 in food at all.

The question of why the UK did not follow the EU ban has not been answered satisfactorily in public documentation. The FSA's review process was thorough and the scientific uncertainty it identified is genuine. But "we cannot prove it harms people at dietary exposure levels" and "it provides no benefit to anyone except manufacturers" is a combination that — in any regulatory framework claiming to apply the precautionary principle — should produce a ban. The EU reached that conclusion. The UK did not.

The next post in this series looks at seed oils — a more contested scientific conversation than titanium dioxide, but one with significantly greater dietary impact given how deeply embedded refined vegetable oils are in the UK food supply. The evidence is more nuanced than either the "seed oils are poison" or "the science is settled" camps tend to acknowledge.